IMATINIB TABLETS 100MG – Third Party Manufacturing

Medizia Biotech is a trusted Third Party Manufacturer of Imatinib Tablets 100mg, offering high-quality oncology formulations manufactured in WHO-GMP compliant facilities. We provide comprehensive contract manufacturing solutions for pharmaceutical companies, marketers, hospitals, distributors, and exporters looking to launch or expand their oncology product portfolio.

Imatinib Tablets 100mg contains Imatinib Mesylate, a targeted anti-cancer medicine used in the treatment of Chronic Myeloid Leukemia (CML), Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL), Gastrointestinal Stromal Tumors (GIST), and other approved indications. Our manufacturing process follows stringent quality control standards to ensure product safety, consistency, and regulatory compliance.

Our Third Party Manufacturing Services

• WHO-GMP compliant manufacturing facility

• High-quality raw materials and stringent quality assurance

• Private labeling and customized packaging

• Custom artwork and branding support

• Competitive pricing with timely delivery

• Low MOQ and small batch manufacturing available

• Bulk production capacity for domestic and export markets

• Dedicated support for Pharma Franchise and marketing companies

Why Choose Medizia Biotech?

• Experienced oncology manufacturing partner

• Advanced production and quality control systems

• Reliable supply chain and on-time deliveries

• Customized packaging options

• Complete documentation and regulatory support

• Trusted partner for third-party and contract manufacturing

If you are looking for a reliable Third Party Manufacturer of Imatinib Tablets 100mg, Medizia Biotech offers end-to-end manufacturing solutions tailored to your business requirements. Contact us today to discuss your manufacturing needs and grow your oncology product portfolio with confidence.